Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07287579
NCT07287579Not yet recruitingNot Applicable

Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in Hair Transplantation in Male Androgenic Alopecia

Sohag University0 sites30 target enrollmentStarted: January 1, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30
Primary Endpoint
• To measure hair density using dermoscopy.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

  • To compare the efficacy of platlet rich plasma and Nanofat injection as adjuvant therapies with FUE hair transplantation in improving graft survival rate,
  • To measure hair density and thickness postoperatively using dermoscopy or trichoscopy.
  • To evaluate patient satisfaction and photographic assessment by blinded evaluators.
  • To assess any adverse effects or complications related to each modality

Detailed Description

  • Ideal candidates for hair transplantation typically present with a clear, stable pattern of hair loss, characterized by at least 50% thinning or balding in 1 or more areas. The scalp must be healthy, with donor hair of good quality and quantity. Patients must have realistic expectations and be free of medical conditions that compromise surgical outcomes. The safe donor zone is located in the mid-occipital region between the upper and lower occipital protuberances, typically containing 65 to 85 follicular units/cm²
  • Intra-operative injection of PRP is beneficial in giving faster density, reducing the catagen loss of transplanted hair, early recovery of the skin, the faster appearance of new anagen hair in FUE hair transplantation.
  • This study compares the effects of PRP and Nano fat as adjuvants in Androgenic alopecia patients undergoing FUE hair transplantation.
  • Nanofat contain stem cells supposed to improve the results of FUE hair transplantation , but the question that we hope to answer at the end of our study which one we recommend as an adjuvant therapy PRP or Nano fat?

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •1. Male patients with stable androgenic alopecia more than 2 years.
  • •Age 20-50 years
  • •No recent medical hair loss treatments.

Exclusion Criteria

  • •1. Active scalp infections or scarring alopecia.
  • •Systemic diseases affecting wound healing.
  • •Platelet disorders or anticoagulant use.
  • •Smoking or heavy alcohol intake

Outcomes

Primary Outcomes

• To measure hair density using dermoscopy.

Time Frame: • All patients will be followed up about 6-12 months postoperative.

To measure how many hair follicles in each cubic centimetre

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shenoda Gamel Fayez

Assistant lecturer in plastic surgery department, faculty of medicine Sohag University hospital.

Sohag University

Similar Trials

Completed
Phase 2
PRP Spinoplasty for Chronic Low Back Pain With Multiple Pathologies: A Quasi-Experimental Study
NCT07268885Allmed Medical Center35
Not yet recruiting
Phase 2
Effectiveness of Platelet Rich Plasma vs dermal fillers for the improvement of deep nasolabial folds - A triple blinded randomised control trial
CTRI/2022/06/043452Soya Alfred Xavier
Recruiting
Phase 4
Effect of Tofacitinib on coagulation and platelet function, and its role in thromboembolic eventsulcerative colitis
2024-518434-83-01Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa60
Completed
Phase 4
A study designed to evaluate a modified Anti-Platelet Therapy (drugs that preventblood platelets from clotting) after implantation of a Firehawk drug-eluting stent (metallic tube, which is covered with a drug and inserted into stenosed blood vessels of the heart in order to keep them open) in patients who have experienced a heart attack and were treated with complete revascularisation (the lesion related to the heart attack and all other significant lesions were treated)Acute Myocardial Infarction
2024-519854-35-00SORIN CRM SAS (Microport CRM)695
Completed
Not Applicable
Effects of Platelet and Leukocyte-rich Fibrin on Alveolar Ridge Maintenance Through Three-dimensional Analysis
NCT07278180University of Guarulhos40